Intrexon reported $-7614000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agenus AGEN:US USD -41645000 2.92M
Amgen AMGN:US USD 2.23B 508M
Anika Therapeutics ANIK:US USD 11.69M 15.07M
Arrowhead Research ARWR:US USD -83830000 10.92M
AstraZeneca AZN:LN USD 1.25B 706M
Bluebird Bio BLUE:US USD -84781000 22.62M
Bristol Myers Squibb BMY:US USD 2.47B 117M
Gilead Sciences GILD:US USD 2.84B 808M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Heron Therapeutics HRTX:US USD -41882000 7.62M
Immunogen IMGN:US USD -77429000 16.38M
Intrexon XON:US USD -7614000 16.55M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Ligand Pharmaceuticals LGND:US USD 636K 695K
Macrogenics MGNX:US USD -24955000 16.85M
Mannkind MNKD:US USD -9610000 10.84M
Merk MRK:US USD 4.01B 913M
Novartis NOVN:VX USD 2.17B 60M
Peregrine Pharmaceuticals PPHM:US USD -2684000 5.42M
Rigel Pharmaceuticals RIGL:US USD -18403000 5.44M
Roche Holding ROG:VX 11.55B 3.47B
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Thermo Fisher Scientific TMO:US USD 1.86B 151M
Veracyte VCYT:US USD -9680000 1.05M
Xencor XNCR:US USD -38348000 10.35M
YTE INCY:US USD 138.38M 116.06M
Ziopharm Oncology ZIOP:US USD -8264000 969K